ORIC FY 2023 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ORICORIC Pharmaceuticals, Inc.

$1B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$111M

Net Income

-$101M

EPS (Diluted)

$-1.96

Cash Flow

Operating Cash Flow

-$86M

Free Cash Flow

-$87M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$255M

Total Liabilities

$31M

Stockholders' Equity

$224M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	$0	—
Operating Income	-$111M	-$92M	-20.7%
Net Income	-$101M	-$89M	-13.0%